234 related articles for article (PubMed ID: 18505918)
1. The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity.
Willis AL; Tran NL; Chatigny JM; Charlton N; Vu H; Brown SA; Black MA; McDonough WS; Fortin SP; Niska JR; Winkles JA; Cunliffe HE
Mol Cancer Res; 2008 May; 6(5):725-34. PubMed ID: 18505918
[TBL] [Abstract][Full Text] [Related]
2. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
3. The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.
Asrani K; Keri RA; Galisteo R; Brown SA; Morgan SJ; Ghosh A; Tran NL; Winkles JA
Mol Cancer Res; 2013 Apr; 11(4):393-404. PubMed ID: 23378579
[TBL] [Abstract][Full Text] [Related]
4. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
5. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.
Tran NL; McDonough WS; Savitch BA; Fortin SP; Winkles JA; Symons M; Nakada M; Cunliffe HE; Hostetter G; Hoelzinger DB; Rennert JL; Michaelson JS; Burkly LC; Lipinski CA; Loftus JC; Mariani L; Berens ME
Cancer Res; 2006 Oct; 66(19):9535-42. PubMed ID: 17018610
[TBL] [Abstract][Full Text] [Related]
6. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
Armstrong CL; Galisteo R; Brown SA; Winkles JA
Oncotarget; 2016 Dec; 7(49):81474-81492. PubMed ID: 27821799
[TBL] [Abstract][Full Text] [Related]
7. Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer.
Connolly NP; Galisteo R; Xu S; Bar EE; Peng S; Tran NL; Ames HM; Kim AJ; Woodworth GF; Winkles JA
Glia; 2021 Sep; 69(9):2199-2214. PubMed ID: 33991013
[TBL] [Abstract][Full Text] [Related]
8. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
[TBL] [Abstract][Full Text] [Related]
9. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
Brown SA; Cheng E; Williams MS; Winkles JA
PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
[TBL] [Abstract][Full Text] [Related]
10. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumors.
Zhou H; Hittelman WN; Yagita H; Cheung LH; Martin SS; Winkles JA; Rosenblum MG
Cancer Res; 2013 Jul; 73(14):4439-50. PubMed ID: 23722548
[TBL] [Abstract][Full Text] [Related]
12. The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion.
Cheng E; Whitsett TG; Tran NL; Winkles JA
Mol Cancer Res; 2015 Mar; 13(3):575-83. PubMed ID: 25392346
[TBL] [Abstract][Full Text] [Related]
13. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
16. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
[TBL] [Abstract][Full Text] [Related]
17. Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.
Whitsett TG; Mathews IT; Cardone MH; Lena RJ; Pierceall WE; Bittner M; Sima C; LoBello J; Weiss GJ; Tran NL
Mol Cancer Res; 2014 Apr; 12(4):550-9. PubMed ID: 24469836
[TBL] [Abstract][Full Text] [Related]
18. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
[TBL] [Abstract][Full Text] [Related]
19. The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment.
Zhou H; Ekmekcioglu S; Marks JW; Mohamedali KA; Asrani K; Phillips KK; Brown SA; Cheng E; Weiss MB; Hittelman WN; Tran NL; Yagita H; Winkles JA; Rosenblum MG
J Invest Dermatol; 2013 Apr; 133(4):1052-62. PubMed ID: 23190886
[TBL] [Abstract][Full Text] [Related]
20. TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression.
Dai L; Gu L; Ding C; Qiu L; Di W
Cancer Lett; 2009 Oct; 283(2):159-67. PubMed ID: 19398263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
